1. Home
  2. CUZ vs KRYS Comparison

CUZ vs KRYS Comparison

Compare CUZ & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUZ
  • KRYS
  • Stock Information
  • Founded
  • CUZ 1958
  • KRYS 2015
  • Country
  • CUZ United States
  • KRYS United States
  • Employees
  • CUZ N/A
  • KRYS N/A
  • Industry
  • CUZ Real Estate Investment Trusts
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CUZ Real Estate
  • KRYS Health Care
  • Exchange
  • CUZ Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • CUZ 4.8B
  • KRYS 4.7B
  • IPO Year
  • CUZ N/A
  • KRYS 2017
  • Fundamental
  • Price
  • CUZ $28.77
  • KRYS $183.36
  • Analyst Decision
  • CUZ Buy
  • KRYS Strong Buy
  • Analyst Count
  • CUZ 10
  • KRYS 9
  • Target Price
  • CUZ $32.80
  • KRYS $203.22
  • AVG Volume (30 Days)
  • CUZ 1.5M
  • KRYS 384.0K
  • Earning Date
  • CUZ 10-30-2025
  • KRYS 11-03-2025
  • Dividend Yield
  • CUZ 4.45%
  • KRYS N/A
  • EPS Growth
  • CUZ N/A
  • KRYS 36.22
  • EPS
  • CUZ 0.37
  • KRYS 4.91
  • Revenue
  • CUZ $917,942,000.00
  • KRYS $359,205,000.00
  • Revenue This Year
  • CUZ $14.21
  • KRYS $34.33
  • Revenue Next Year
  • CUZ $2.84
  • KRYS $47.84
  • P/E Ratio
  • CUZ $77.47
  • KRYS $37.38
  • Revenue Growth
  • CUZ 11.98
  • KRYS 116.08
  • 52 Week Low
  • CUZ $24.07
  • KRYS $122.80
  • 52 Week High
  • CUZ $32.55
  • KRYS $207.84
  • Technical
  • Relative Strength Index (RSI)
  • CUZ 50.60
  • KRYS 76.57
  • Support Level
  • CUZ $28.54
  • KRYS $158.08
  • Resistance Level
  • CUZ $29.30
  • KRYS $183.36
  • Average True Range (ATR)
  • CUZ 0.48
  • KRYS 6.02
  • MACD
  • CUZ -0.04
  • KRYS 2.37
  • Stochastic Oscillator
  • CUZ 51.39
  • KRYS 99.31

About CUZ Cousins Properties Incorporated

Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: